Drug Type CAR-T |
Synonyms- |
Action modulators, inhibitors |
Mechanism IL-12R modulators(Interleukin-12 receptor modulators), IL-13Rα2 inhibitors(Interleukin-13 receptor subunit alpha-2 inhibitors), IL18R1 modulators(Interleukin 18 receptor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Glioblastoma | Preclinical | United States | 23 Feb 2025 |





